Corrected Transcript


1-877-FACTSET
 
www.callstreet.com


Total Pages
:
 
19


Copyright © 2001-2011 FactSet CallStreet, LLC


07
-
Apr
-
2011


ProMetic Life Sciences, Inc.
 
(PLI.CA)


Q4 2010 Earnings Call
ProMetic Life Sciences, Inc.
 
(
PLI.CA
)


Q4 2010 Earnings Ca
ll


Corrected Transcript


07
-
Apr
-
2011


1
-
877
-
FACTSET
 
www.callstreet.com


2


Copyright
 
©
 
2001
-
2011
 
FactSet
 
CallStreet, LLC


CORPORATE PARTICIPANTS


Pierre Laurin


President & Chief Executive Officer, ProMetic Life Sciences, Inc.


Bruce Philip Pritchard


Chief Operating Officer & Chief Financial Officer, ProMetic Life Sciences, Inc.


......................................................................................................................................................................................................................................................


MANAGEMENT DISCUSSION SECTION


Operator
:
 
Good day, everyone. Welcome to Conference Call for ProMetic Life Sciences Incorporated Financial


Results for 2010. I would like to introduce Mr. Pierre Laurin, ProMetic's President and Chief Executive Officer; and


Mr. Bruce Pritchard, Chief Financial Officer. For your information, the presentation will be followed by a question-


and-answer period. Please note that since we are expecting a large number of participants, questions will be


limited to two per participant and this on a rotation basis.


[Foreign Language] (00:00:36-00:01:14).


I would now like to turn the conference over to Mr. Laurin.


[Foreign Language] (00:01:19).


......................................................................................................................................................................................................................................................


Pierre Laurin


President & Chief Executive Officer, ProMetic Life Sciences, Inc.


Thank you, France, and good morning, everyone, and thank you for taking the time out of your busy schedule to


listen to this morning webcast. As you will be aware from the recent press announcements, the past few days


have been very busy, not to say fruitful for the company.


On slide 2, as always, I'd draw your attention to the standard disclaimer regarding forward-looking statement,


which will be made during this morning presentation.


Let's move to slide 3, as we [indiscernible] (00:01:48) this morning webcast will give you a sense that ProMetic


has weathered the recent financial storm. We have suffered a few bruises along the way. But we have survived


and are on the other end in good shape and ready to deliver. Later, I will ask our CFO, Bruce Pritchard, to provide


commentary on the 2010 results and recent post balance sheet events.


And we'll go on to outline our plans for driving the business forward and creating value from each of our


operations before wrapping it up with what I hope will be a fruitful question-and-answer session. So, let's kick out


with a slide 4, as a reminder for some of our newer investors as to what ProMetic is all about.


Firstly, who are we? Our name defines who we are. ProMetic is derived from the words protein mimetic. At


ProMetic, we design small chemical molecules that mimic unique and specific interactions between proteins.


These proprietary chemical structures can be used in a myriad of commercial applications when incorporated into


filters. ProMetic creates affinity filters that bind and recover high level of the valuable therapeutic proteins and the